HIV Diagnosis and Treatment Market
HIV Diagnosis and Treatment Market Size, Share & Trends Analysis by Product Type (Diagnostic Tests and Antiretroviral Therapy (ART) Drugs), by Diagnostic Type (Screening Tests, Confirmatory Tests, Monitoring Tests, and Specialized Diagnostic Tests), by Route of Administration (Oral and Injectable), by End-Users (Hospitals, Diagnostic Laboratories, Home Care Settings, and Specialty Clinics), Forecast Period (2026-2035)
Industry Overview
Global HIV diagnosis and treatment market was valued at $39.5 billion in 2025 and is projected to reach $66.3 billion by 2035, growing at a CAGR of 5.3% from 2026 to 2035. The growth of the market is primarily supported by the sustained demand for effective therapeutic options and reliable diagnostic solutions. Continued advancements in treatment formulations and testing technologies have improved accessibility and clinical outcomes. In addition, increasing awareness and early detection initiatives have contributed to higher adoption rates across healthcare systems. Expanding distribution networks, particularly in emerging economies, further support market expansion. The presence of established pharmaceutical and diagnostic manufacturers ensures consistent product availability and innovation. Collectively, these factors contribute to the steady progression of the market over time.
Market Dynamics
Shift Toward Long-Acting Treatment Regimens
The market is witnessing a gradual transition from daily oral therapies to long-acting treatment options that offer extended dosing intervals. This shift is improving patient adherence and reducing the burden of frequent medication intake. Pharmaceutical companies are focusing on developing injectable formulations with sustained efficacy and safety profiles. The adoption of such therapies is gaining traction in developed healthcare systems and is expected to expand further. In addition, healthcare providers are increasingly considering these options for long-term disease management. This trend is contributing to a more patient-centric approach in treatment delivery.
Expansion of Advanced Diagnostic Technologies
Advancements in diagnostic technologies are enhancing the accuracy and speed of disease detection and monitoring. The increasing use of molecular testing and point-of-care solutions is enabling earlier diagnosis and timely intervention. These innovations are particularly valuable in resource-limited settings where access to centralized laboratories is limited. Manufacturers are introducing more efficient and user-friendly diagnostic products to meet growing demand. Furthermore, integration of advanced diagnostics into routine screening programs is supporting wider adoption. This trend is strengthening the overall diagnostic landscape and improving clinical decision-making.
Market Segmentation
- Based on the product type, the market is segmented into diagnostic tests and antiretroviral therapy (ART) drugs.
- Based on the diagnostic type, the market is segmented into screening tests, confirmatory tests, monitoring tests, and specialized diagnostic tests.
- Based on the route of administration, the market is segmented into oral and injectable.
- Based on the end-users, the market is segmented into hospitals, diagnostic laboratories, home care settings, and specialty clinics.
Antiretroviral Therapy (ART) Drugs Segment to Lead the Market with the Largest Share
The segment continues to expand due to sustained demand for effective and durable treatment options across both developed and emerging markets. Leading manufacturers such as Gilead Sciences Inc and ViiV Healthcare Limited maintain strong positions through well-established product portfolios and ongoing formulation improvements. There is a noticeable shift toward simplified regimens and combination therapies aimed at improving patient adherence. In addition, the introduction of long-acting injectable therapies is gradually reshaping treatment practices in certain regions. Generic drug producers, including Cipla Limited and Aurobindo Pharma Limited, are supporting volume growth by improving affordability in cost-sensitive markets. Overall, consistent innovation and wider treatment access remain central to the segment’s progression.
Monitoring Tests: A Key Segment in Market Growth
Growth within this segment is supported by the increasing emphasis on routine disease tracking and treatment effectiveness assessment. Companies such as F Hoffmann-La Roche Ltd and Abbott Laboratories play a key role by offering advanced viral load and CD4 testing solutions. The adoption of automated and high-throughput diagnostic platforms is enhancing efficiency in clinical laboratories. There is also a gradual shift toward decentralized testing approaches to improve access in remote settings. Continuous improvements in test accuracy and turnaround time are strengthening clinical confidence in monitoring practices. As treatment coverage expands globally, the demand for reliable monitoring solutions is expected to remain steady.
Regional Outlook
The global HIV diagnosis and treatment market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Region Dominates the Market with Major Share
The region maintains a leading position due to its established healthcare infrastructure and strong access to advanced treatment and diagnostic options. Market growth is supported by the presence of major companies such as Gilead Sciences Inc and Abbott Laboratories, which continue to introduce improved therapies and testing solutions. There is a steady shift toward long-acting treatment approaches and integrated care models. In addition, early diagnosis and routine monitoring practices are well embedded within clinical systems. Favorable reimbursement structures further contribute to sustained product uptake. Ongoing product innovation and stable demand continue to reinforce the region’s market position.
Asia-Pacific to Witness as a Fastest Growing Region
This region is experiencing the fastest expansion, supported by increasing healthcare investments and broader access to treatment programs. Companies such as Cipla Limited and Aurobindo Pharma Limited are actively contributing through large-scale supply of cost-effective therapies. There is a rising focus on expanding diagnostic coverage, particularly in underserved areas. Governments and healthcare organizations are strengthening screening and treatment initiatives, leading to higher product demand. In addition, improving distribution networks facilitates access to both drugs and diagnostic tools. The combination of affordability and expanding healthcare reach is driving consistent growth across the region.
Market Players Outlook
The major companies operating in the global HIV diagnosis and treatment market include Gilead Sciences Inc., ViiV Healthcare Ltd., Merck & Co Inc., Johnson & Johnson, and Abbott Laboratories, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In June 2025, Gilead Sciences Inc announced the FDA approval and launch of lenacapavir (Yeztugo), a twice-yearly injectable HIV prevention therapy. This product represents a major advancement as it significantly reduces dosing frequency compared to daily oral regimens. The therapy demonstrated near-complete prevention efficacy in clinical trials and is positioned as a breakthrough in HIV prevention. The company initiated commercial rollout in the U.S. with plans for global expansion through partnerships. This launch reflects a clear shift toward long-acting treatment and prevention solutions in the market.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global HIV diagnosis and treatment market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global HIV Diagnosis and Treatment Market Sales Analysis – Product Type | Diagnostic Type | Route of Administration | End-Users | ($ Million)
- HIV Diagnosis and Treatment Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key HIV Diagnosis and Treatment Industry Trends
- Market Recommendations
- Porter's Five Forces Analysis for the HIV Diagnosis and Treatment Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global HIV Diagnosis and Treatment Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global HIV Diagnosis and Treatment Market: Impact Analysis
- Market Opportunities
- Opportunities For Global HIV Diagnosis and Treatment Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – HIV Diagnosis and Treatment Market Revenue and Share by Manufacturers
- HIV Diagnosis and Treatment Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Abbott Laboratories
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Gilead Sciences Inc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Johnson & Johnson
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merck & Co Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- ViiV Healthcare Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Abbott Laboratories
- Key Company Analysis
- Global HIV Diagnosis and Treatment Market Sales Analysis by Product Type ($ Million)
- Diagnostic Tests
- Antiretroviral Therapy (ART) Drugs
- Global HIV Diagnosis and Treatment Market Sales Analysis by Diagnostic Type ($ Million)
- Screening Tests
- Confirmatory Tests
- Monitoring Tests
- Specialized Diagnostic Tests
- Global HIV Diagnosis and Treatment Market Sales Analysis by Route of Administration ($ Million)
- Oral
- Injectable
- Global HIV Diagnosis and Treatment Market Sales Analysis by End-Users ($ Million)
- Hospitals
- Diagnostic Laboratories
- Home Care Settings
- Specialty Clinics
- Regional Analysis
- North American HIV Diagnosis and Treatment Market Sales Analysis – Product Type | Diagnostic Type | Route of Administration | End-Users | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European HIV Diagnosis and Treatment Market Sales Analysis – Product Type | Diagnostic Type | Route of Administration | End-Users | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific HIV Diagnosis and Treatment Market Sales Analysis – Product Type | Diagnostic Type | Route of Administration | End-Users | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Others)
- Rest of Asia-Pacific
- Rest of the World HIV Diagnosis and Treatment Market Sales Analysis – Product Type | Diagnostic Type | Route of Administration | End-Users | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AbbVie Inc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Aurobindo Pharma Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Becton Dickinson and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bio Rad Laboratories Inc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boehringer Ingelheim International GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bristol Myers Squibb Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cipla Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Danaher Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Dr Reddy’s Laboratories Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- F Hoffmann La Roche Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Gilead Sciences Inc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Johnson & Johnson
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lupin Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Macleods Pharmaceuticals Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck & Co Inc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pfizer Inc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Qiagen NV
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siemens Healthineers AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sun Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Teva Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Viatris Inc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ViiV Healthcare Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zydus Lifesciences Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
1. Global HIV Diagnosis and Treatment Market Research And Analysis By Product Type, 2025-2035 ($ Million)
2. Global HIV Diagnostic Tests Market Research And Analysis By Region, 2025-2035 ($ Million)
3. Global HIV Antiretroviral Therapy (ART) Drugs Market Research And Analysis By Region, 2025-2035 ($ Million)
4. Global HIV Diagnosis and Treatment Market Research And Analysis By Diagnostic Type, 2025-2035 ($ Million)
5. Global HIV Diagnosis and Treatment by Screening Tests Market Research And Analysis By Region, 2025-2035 ($ Million)
6. Global HIV Diagnosis and Treatment by Confirmatory Tests Market Research And Analysis By Region, 2025-2035 ($ Million)
7. Global HIV Diagnosis and Treatment by Monitoring Tests Market Research And Analysis By Region, 2025-2035 ($ Million)
8. Global HIV Diagnosis and Treatment by Specialized Diagnostic Tests Market Research And Analysis By Region, 2025-2035 ($ Million)
9. Global HIV Diagnosis and Treatment Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
10. Global HIV Diagnosis and Treatment by Oral Market Research And Analysis By Region, 2025-2035 ($ Million)
11. Global HIV Diagnosis and Treatment by Injectable Market Research And Analysis By Region, 2025-2035 ($ Million)
12. Global HIV Diagnosis and Treatment Market Research And Analysis By End-Users, 2025-2035 ($ Million)
13. Global HIV Diagnosis and Treatment For Hospitals Market Research And Analysis By Region, 2025-2035 ($ Million)
14. Global HIV Diagnosis and Treatment For Diagnostic Laboratories Market Research And Analysis By Region, 2025-2035 ($ Million)
15. Global HIV Diagnosis and Treatment For Home Care Settings Market Research And Analysis By Region, 2025-2035 ($ Million)
16. Global HIV Diagnosis and Treatment For Specialty Clinics Market Research And Analysis By Region, 2025-2035 ($ Million)
17. Global HIV Diagnosis and Treatment Market Research And Analysis By Geography, 2025-2035 ($ Million)
18. North American HIV Diagnosis and Treatment Market Research And Analysis By Country, 2025-2035 ($ Million)
19. North American HIV Diagnosis and Treatment Market Research And Analysis By Product Type, 2025-2035 ($ Million)
20. North American HIV Diagnosis and Treatment Market Research And Analysis By Diagnostic Type, 2025-2035 ($ Million)
21. North American HIV Diagnosis and Treatment Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
22. North American HIV Diagnosis and Treatment Market Research And Analysis By End-Users, 2025-2035 ($ Million)
23. European HIV Diagnosis and Treatment Market Research And Analysis By Country, 2025-2035 ($ Million)
24. European HIV Diagnosis and Treatment Market Research And Analysis By Product Type, 2025-2035 ($ Million)
25. European HIV Diagnosis and Treatment Market Research And Analysis By Diagnostic Type, 2025-2035 ($ Million)
26. European HIV Diagnosis and Treatment Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
27. European HIV Diagnosis and Treatment Market Research And Analysis By End-Users, 2025-2035 ($ Million)
28. Asia-Pacific HIV Diagnosis and Treatment Market Research And Analysis By Country, 2025-2035 ($ Million)
29. Asia-Pacific HIV Diagnosis and Treatment Market Research And Analysis By Product Type, 2025-2035 ($ Million)
30. Asia-Pacific HIV Diagnosis and Treatment Market Research And Analysis By Diagnostic Type, 2025-2035 ($ Million)
31. Asia-Pacific HIV Diagnosis and Treatment Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
32. Asia-Pacific HIV Diagnosis and Treatment Market Research And Analysis By End-Users, 2025-2035 ($ Million)
33. Rest Of The World HIV Diagnosis and Treatment Market Research And Analysis By Country, 2025-2035 ($ Million)
34. Rest Of The World HIV Diagnosis and Treatment Market Research And Analysis By Product Type, 2025-2035 ($ Million)
35. Rest Of The World HIV Diagnosis and Treatment Market Research And Analysis By Diagnostic Type, 2025-2035 ($ Million)
36. Rest Of The World HIV Diagnosis and Treatment Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
37. Rest Of The World HIV Diagnosis and Treatment Market Research And Analysis By End-Users, 2025-2035 ($ Million)
1. Global HIV Diagnosis and Treatment Market Share By Product Type, 2025 Vs 2035 (%)
2. Global HIV Diagnostic Tests Market Share By Region, 2025 Vs 2035 (%)
3. Global HIV Antiretroviral Therapy (ART) Drugs Market Share By Region, 2025 Vs 2035 (%)
4. Global HIV Diagnosis and Treatment Market Share By Diagnostic Type, 2025 Vs 2035 (%)
5. Global HIV Diagnosis and Treatment by Screening Tests Market Share By Region, 2025 Vs 2035 (%)
6. Global HIV Diagnosis and Treatment by Confirmatory Tests Market Share By Region, 2025 Vs 2035 (%)
7. Global HIV Diagnosis and Treatment by Monitoring Tests Market Share By Region, 2025 Vs 2035 (%)
8. Global HIV Diagnosis and Treatment by Specialized Diagnostic Tests Market Share By Region, 2025 Vs 2035 (%)
9. Global HIV Diagnosis and Treatment Market Share By Route of Administration, 2025 Vs 2035 (%)
10. Global HIV Diagnosis and Treatment by Oral Market Share By Region, 2025 Vs 2035 (%)
11. Global HIV Diagnosis and Treatment by Injectable Market Share By Region, 2025 Vs 2035 (%)
12. Global HIV Diagnosis and Treatment Market Share By End-Users, 2025 Vs 2035 (%)
13. Global HIV Diagnosis and Treatment For Hospitals Market Share By Region, 2025 Vs 2035 (%)
14. Global HIV Diagnosis and Treatment For Diagnostic Laboratories Market Share By Region, 2025 Vs 2035 (%)
15. Global HIV Diagnosis and Treatment For Home Care Settings Market Share By Region, 2025 Vs 2035 (%)
16. Global HIV Diagnosis and Treatment For Specialty Clinics Market Share By Region, 2025 Vs 2035 (%)
17. Global HIV Diagnosis and Treatment Market Share By Region, 2025 Vs 2035 (%)
18. US HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
19. Canada HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
20. UK HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
21. France HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
22. Germany HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
23. Italy HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
24. Spain HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
25. Russia HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
26. Rest Of Europe HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
27. India HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
28. China HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
29. Japan HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
30. South Korea HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
31. ASEAN HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
32. Australia and New Zealand HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
33. Rest Of Asia-Pacific HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
34. Latin America HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
35. Middle East And Africa HIV Diagnosis and Treatment Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of users within the company
